{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:11:34Z","timestamp":1761059494016},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T00:00:00Z","timestamp":1364256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s10552-013-0182-4","type":"journal-article","created":{"date-parts":[[2013,3,25]],"date-time":"2013-03-25T06:01:07Z","timestamp":1364191267000},"page":"1045-1052","source":"Crossref","is-referenced-by-count":12,"title":["Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case\u2013control series of veterans"],"prefix":"10.1007","volume":"24","author":[{"given":"Jean-Alfred","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodi A.","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel L.","family":"Banez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Hoyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delores","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Demark-Wahnefried","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Platz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Shuler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enwono","family":"Eyoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Calloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Freedland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,26]]},"reference":[{"key":"182_CR1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.pcan.4500421","volume":"3","author":"R Kaaks","year":"2000","unstructured":"Kaaks R, Lukanova A, Sommersberg B (2000) Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review. Prostate Cancer Prostatic Dis 3:157\u2013172","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"182_CR2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jsbmb.2004.10.002","volume":"92","author":"EA Platz","year":"2004","unstructured":"Platz EA, Giovannucci E (2004) The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer. J Steroid Biochem Mol Biol 92:237\u2013253","journal-title":"J Steroid Biochem Mol Biol"},{"key":"182_CR3","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ijc.22814","volume":"121","author":"RC Travis","year":"2007","unstructured":"Travis RC, Key TJ, Allen NE, Appleby PN, Roddam AW, Rinaldi S et al (2007) Serum androgens and prostate cancer among 643 cases and 643 controls in the European prospective investigation into cancer and nutrition. Int J Cancer 121:1331\u20131338","journal-title":"Int J Cancer"},{"key":"182_CR4","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1001\/jama.296.19.2351","volume":"296","author":"LS Marks","year":"2006","unstructured":"Marks LS, Mazer NA, Mostaghel E, Hess DL, Dorey FJ, Epstein JI et al (2006) Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. JAMA 296:2351\u20132361","journal-title":"JAMA"},{"key":"182_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399402005112","volume":"4","author":"JA Ellis","year":"2002","unstructured":"Ellis JA, Sinclair R, Harrap SB (2002) Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med 4:1\u201311","journal-title":"Expert Rev Mol Med"},{"key":"182_CR6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ecl.2007.03.004","volume":"36","author":"N Otberg","year":"2007","unstructured":"Otberg N, Finner AM, Shapiro J (2007) Androgenetic alopecia. Endocrinol Metab Clin North Am 36:379\u2013398","journal-title":"Endocrinol Metab Clin North Am"},{"key":"182_CR7","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1749-6632.1951.tb31971.x","volume":"53","author":"JB Hamilton","year":"1951","unstructured":"Hamilton JB (1951) Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 53:708\u2013728","journal-title":"Ann N Y Acad Sci"},{"key":"182_CR8","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0090-4295(98)00108-3","volume":"51","author":"BR Oh","year":"1998","unstructured":"Oh BR, Kim SJ, Moon JD, Kim HN, Kwon DD, Won YH et al (1998) Association of benign prostatic hyperplasia with male pattern baldness. Urology 51:744\u2013748","journal-title":"Urology"},{"key":"182_CR9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1524-4725.2004.30213.x","volume":"30","author":"MJ Rapaport","year":"2004","unstructured":"Rapaport MJ (2004) Follow-up of 1\u00a0mg finasteride treatment of male pattern baldness-difference between clinical trials and private office follow-up: influences on prescribing habits evaluated. Dermatol Surg 30:761\u2013763","journal-title":"Dermatol Surg"},{"key":"182_CR10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2003.11.001","volume":"44","author":"IM Thompson","year":"2003","unstructured":"Thompson IM, Klein EA, Lippman SM, Coltman CA, Djavan B (2003) Prevention of prostate cancer with finasteride: US\/European perspective. Eur Urol 44:650\u2013655","journal-title":"Eur Urol"},{"key":"182_CR11","first-page":"325","volume":"9","author":"W Demark-Wahnefried","year":"2000","unstructured":"Demark-Wahnefried W, Schildkraut JM, Thompson D, Lesko SM, McIntyre L, Schwingl P et al (2000) Early onset baldness and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 9:325\u2013328","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"182_CR12","first-page":"549","volume":"11","author":"GG Giles","year":"2002","unstructured":"Giles GG, Severi G, Sinclair R, English DR, McCredie MR, Johnson W et al (2002) Androgenetic alopecia and prostate cancer: findings from an Australian case-control study. Cancer Epidemiol Biomarkers Prev 11:549\u2013553","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"182_CR13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.canep.2010.02.003","volume":"34","author":"JL Wright","year":"2010","unstructured":"Wright JL, Page ST, Lin DW, Stanford JL (2010) Male pattern baldness and prostate cancer risk in a population-based case-control study. Cancer Epidemiol 34:131\u2013135","journal-title":"Cancer Epidemiol"},{"key":"182_CR14","first-page":"523","volume":"9","author":"E Hawk","year":"2000","unstructured":"Hawk E, Breslow RA, Graubard BI (2000) Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 9:523\u2013527","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"182_CR15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/jnci\/53.2.341","volume":"53","author":"P Greenwald","year":"1974","unstructured":"Greenwald P, Damon A, Kirmss V, Polan AK (1974) Physical and demographic features of men before developing cancer of the prostate. J Natl Cancer Inst 53:341\u2013346","journal-title":"J Natl Cancer Inst"},{"key":"182_CR16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/(SICI)1097-0215(19990301)80:5<699::AID-IJC12>3.0.CO;2-7","volume":"80","author":"CC Hsieh","year":"1999","unstructured":"Hsieh CC, Thanos A, Mitropoulos D, Deliveliotis C, Mantzoros CS, Trichopoulos D (1999) Risk factors for prostate cancer: a case-control study in Greece. Int J Cancer 80:699\u2013703","journal-title":"Int J Cancer"},{"key":"182_CR17","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/annonc\/mdq695","volume":"22","author":"M Yassa","year":"2011","unstructured":"Yassa M, Saliou M, De Rycke Y, Hemery C, Henni M, Bachaud JM et al (2011) Male pattern baldness and the risk of prostate cancer. Ann Oncol 22:1824\u20131827","journal-title":"Ann Oncol"},{"key":"182_CR18","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1016\/j.ejca.2010.05.020","volume":"46","author":"RG Cremers","year":"2010","unstructured":"Cremers RG, Aben KK, Vermeulen SH, den Heijer M, van Oort IM, Kiemeney LA (2010) Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer. Eur J Cancer 46:3294\u20133299","journal-title":"Eur J Cancer"},{"key":"182_CR19","first-page":"27","volume":"2","author":"AW Hsing","year":"1993","unstructured":"Hsing AW, Comstock GW (1993) Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer. Cancer Epidemiol Biomarkers Prev 2:27\u201332","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"182_CR20","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/jnci\/88.16.1118","volume":"88","author":"PH Gann","year":"1996","unstructured":"Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ (1996) Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 88:1118\u20131126","journal-title":"J Natl Cancer Inst"},{"key":"182_CR21","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1158\/1055-9965.EPI-04-0371","volume":"14","author":"EA Platz","year":"2005","unstructured":"Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ et al (2005) Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiol Biomarkers Prev 14:1262\u20131269","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"182_CR22","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.4065\/80.10.1316","volume":"80","author":"D Stough","year":"2005","unstructured":"Stough D, Stenn K, Haber R, Parsley WM, Vogel JE, Whiting DA et al (2005) Psychological effect, pathophysiology, and management of androgenetic alopecia in men. Mayo Clin Proc 80:1316\u20131322","journal-title":"Mayo Clin Proc"},{"key":"182_CR23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.semcdb.2007.02.004","volume":"18","author":"VA Randall","year":"2007","unstructured":"Randall VA (2007) Hormonal regulation of hair follicles exhibits a biological paradox. Semin Cell Dev Biol 18:274\u2013285","journal-title":"Semin Cell Dev Biol"},{"key":"182_CR24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1523-1747.2001.01261.x","volume":"116","author":"JA Ellis","year":"2001","unstructured":"Ellis JA, Stebbing M, Harrap SB (2001) Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Invest Dermatol 116:452\u2013455","journal-title":"J Invest Dermatol"},{"key":"182_CR25","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/jama.1993.03500080046030","volume":"269","author":"SM Lesko","year":"1993","unstructured":"Lesko SM, Rosenberg L, Shapiro S (1993) A case-control study of baldness in relation to myocardial infarction in men. JAMA: J Am Med Assoc 269:998\u20131003","journal-title":"JAMA: J Am Med Assoc"},{"key":"182_CR26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwm365","volume":"167","author":"E Shahar","year":"2008","unstructured":"Shahar E, Heiss G, Rosamond WD, Szklo M (2008) Baldness and myocardial infarction in men: the atherosclerosis risk in communities study. Am J Epidemiol 167:676\u2013683","journal-title":"Am J Epidemiol"},{"key":"182_CR27","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/0002-8703(95)90201-5","volume":"130","author":"P Schnohr","year":"1995","unstructured":"Schnohr P, Lange P, Nyboe J, Appleyard M, Jensen G (1995) Gray hair, baldness, and wrinkles in relation to myocardial infarction: the Copenhagen city heart study. Am Heart J 130:1003\u20131010","journal-title":"Am Heart J"},{"key":"182_CR28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.annepidem.2005.02.013","volume":"15","author":"AJ Littman","year":"2005","unstructured":"Littman AJ, White E (2005) Reliability and validity of self-reported male balding patterns for use in epidemiologic studies. Ann Epidemiol 15:771\u2013772","journal-title":"Ann Epidemiol"},{"key":"182_CR29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2458-4-60","volume":"4","author":"R Taylor","year":"2004","unstructured":"Taylor R, Matassa J, Leavy JE, Fritschi L (2004) Validity of self reported male balding patterns in epidemiological studies. BMC Public Health 4:60","journal-title":"BMC Public Health"},{"key":"182_CR30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0190-9622(99)70188-X","volume":"40","author":"LB Signorello","year":"1999","unstructured":"Signorello LB, Wuu J, Hsieh C, Tzonou A, Trichopoulos D, Mantzoros CS (1999) Hormones and hair patterning in men: a role for insulin-like growth factor 1? J Am Acad Dermatol 40:200\u2013203","journal-title":"J Am Acad Dermatol"},{"key":"182_CR31","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1067\/mjd.2000.103987","volume":"42","author":"EA Platz","year":"2000","unstructured":"Platz EA, Pollak MN, Willett WC, Giovannucci E (2000) Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3. J Am Acad Dermatol 42:1003\u20131007","journal-title":"J Am Acad Dermatol"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-013-0182-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-013-0182-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-013-0182-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:06:25Z","timestamp":1559235985000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-013-0182-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,26]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["182"],"URL":"https:\/\/doi.org\/10.1007\/s10552-013-0182-4","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,26]]}}}